March 27 – 28, 2025 | Boston, MA| Next Gen Omics and Spatial Biology US 2025 April 25 – 30, 2025 | Chicago, IL | AACR Annual Meeting May 6, 2025 | Denver, CO | 2025 Structural Biology, Biochemistry and Biophysics Symposium at the University of Colorado Anschutz May 16 – 21, 2025 | San Francisco, CA| ATS 2025 International Conference May 30 – June 3, 2025 | 2025 ASCO Annual Meeting June 24, 2025 | Denver, CO | Mountain West BioLife Summit Presentation and Panel hosted by Brianna Phillips, VP Quality & Regulatory, Biodesix June 26 – 28, 2025 | Nashville, TN | 2nd Annual APAPP National Conference August 14 – 16, 2025 | Chicago, IL | AABIP 6^th Annual Conference October 9 – 11, 2025 | Denver, CO | Go2 2025 Centers of Excellence Summit October 19 – 22 | Chicago, IL | CHEST 2025

Precision Med TriCon (PMTC) Presentation by Howard I. Scher, Head of Biomarker Development Program, Memorial Sloan Kettering Cancer Center on "Accelerating Drug Development in Prostate Cancer Using MRD as an Endpoint".

9^th Annual Liquid Biopsy for Precision Oncology Summit Panel Discussion moderated by Matthew Pink Vice President of Business Development, Biodesix: Harnessing MRD & ctDNA to Inform Clinical Trial Decision Making & Improve Dosage Regimens Presentation by Gary Pestano, Ph.D., Chief Development Officer, Biodesix: Empowering Precision Oncology & MRD Monitoring through ctDNA & CTC Analysis – Sponsored by Bio-Rad Laboratories

---

Friends of Cancer Research Advancing the Future of Diagnostics and Regulatory Innovations White Paper co-authored Gary Pestano, Ph.D., Chief Development Officer, Biodesix and Brianna Phillips, Vice President of Quality and Regulatory Affairs, Biodesix: Innovative Validation and Regulatory Processes for Companion Diagnostic Tests for Rare Biomarkers or Indications

AMP 2024 Annual Meeting & Expo Presentation by Gary Pestano, Ph.D., Chief Development Officer, Biodesix: Droplet Digital PCR (ddPCR) in Precision Oncology and MRD: Perspectives from the Trenches Poster Presentation by Leisa Jackson, Staff Scientist, Biodesix & Gary Pestano, Ph.D., Chief Development Officer, Biodesix: TT037 Development of a Clinical-Grade Droplet Digital PCR Workflow for Blood-Based Detection of Cancer Relevant miRNAs presented

---

ISPOR Europe 2024 Poster presentations by Kimberly Le, PharmD, Director of Health Economics Outcomes Research, Biodesix: EPH31: Incidence of Pulmonary Nodules (PNs) During the Coronavirus Disease (COVID-19) Pandemic in the United States (US) EPH93: Prevalence of Pulmonary Nodules (PNs) in 2020 During the Coronavirus Disease (COVID-19) Pandemic in the United States (US) EE438: Economic Impact Model to Estimate the Value of Blood-Based Biomarkers in the Risk Assessment of Pulmonary Nodules (PNS) From a Health System Perspective EPH208: Prevalence of Pulmonary Nodules (PNs) in 2019 in the United States (US) EHP209: Incidence of Pulmonary Nodules (PNs) in 2019 in the United States (US) CO183: Clinical Impact Model for Blood-Based Biomarkers in the Risk Assessment of Pulmonary Nodules (PNs) From a Health System Perspective

---

AACR Special Conference in Cancer Research: Liquid Biopsy: From Discovery to Clinical Implementation Poster Presentation by Colin McDowell, Ph.D. Senior Manager of Business Development, Biodesix: A032 Performance evaluation of a new protein stabilizing blood collection tube with a novel whole blood separation device for clinical plasma proteomics

CHEST 2024 Annual Meeting CHEST Learning Theater Presentation by Sonali Sethi, MD, FCCP, Pulmonary Medicine, Cleveland Clinic and D. Kyle Hogarth, MD, FCCP, Professor of Medicine, University of Chicago: “Patient impact & case studies - the real-world value of biomarkers in lung nodule management”

Go2 for Lung Cancer Centers of Excellence (COE) Summit

---

Droplet Digital PCR World 2024 Asia Presentation by Gary Pestano, Ph.D., Chief Development Officer, Biodesix: From Feasibility to Clinical Testing for Rare Variants in Oncology: 10 years of ddPCR Experiences